Position history for Aberdeen Group plc's holdings in ABBOTT LABORATORIES
Aberdeen Group plc holds 2M shares of ABT (ABBOTT LABORATORIES), worth $209.8M as of 2026-Q1. The position was increased (+2.5% shares). ABT represents 0.3% of Aberdeen Group plc's portfolio.
Current Value
$209.8M
Current Shares
2M
Total Value Change
+$86.6M
Total Shares Change
+858,228
Other major holders of ABT: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Increased |
| 2M |
+2.5% |
| $209.8M |
| 0.3% |
| $113.61 |
37 |
| 2025-Q4 | Increased | 2M | +1.2% | $249.8M | 0.4% | $125.15 | 37 |
| 2025-Q3 | Decreased | 2M | -2.4% | $262.1M | 0.4% | $131.85 | 0 |
| 2025-Q2 | Increased | 2M | +4.2% | $272.9M | 0.5% | $132.52 | 38 |
| 2025-Q1 | Increased | 1.9M | +51.9% | $256M | 0.5% | $128.41 | 51 |
| 2024-Q4 | Increased | 1.3M | +3.0% | $143.8M | 0.3% | $110.14 | 37 |
| 2024-Q3 | Increased | 1.2M | +4.5% | $139.2M | 0.3% | $109.27 | 38 |
| 2024-Q2 | Decreased | 1.2M | -1.9% | $123.2M | 0.2% | $100.45 | 0 |